Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums

User menu

  • My alerts

Search

  • Advanced search
The College of Family Physicians of Canada
  • Other Publications
    • http://www.cfpc.ca/Canadianfamilyphysician/
    • https://www.cfpc.ca/Login/
    • Careers and Locums
  • My alerts
The College of Family Physicians of Canada

Advanced Search

  • Home
  • Articles
    • Current
    • Published Ahead of Print
    • Archive
    • Supplemental Issues
    • Collections - French
    • Collections - English
  • Info for
    • Authors & Reviewers
    • Submit a Manuscript
    • Advertisers
    • Careers & Locums
    • Subscribers
    • Permissions
  • About CFP
    • About CFP
    • About the CFPC
    • Editorial Advisory Board
    • Terms of Use
    • Contact Us
  • Feedback
    • Feedback
    • Rapid Responses
    • Most Read
    • Most Cited
    • Email Alerts
  • Blogs
    • Latest Blogs
    • Blog Guidelines
    • Directives pour les blogues
  • Mainpro+ Credits
    • About Mainpro+
    • Member Login
    • Instructions
  • RSS feeds
  • Follow cfp Template on Twitter
  • LinkedIn
  • Instagram
Research ArticlePractice

Adult pneumococcal immunization

Pamela Liao and Vivien Brown
Canadian Family Physician September 2015; 61 (9) 763;
Pamela Liao
Family medicine resident at the University of Toronto in Ontario.
MD NCMP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vivien Brown
Assistant Professor in the Department of Family and Community Medicine at the University of Toronto.
MD CM CCFP FCFP NCMP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: vbmd@outlook.com
  • Article
  • eLetters
  • Info & Metrics
  • PDF
Loading

Only 16.7% of Canadian adults (18 to 64 years of age) with chronic medical conditions are immunized against Streptococcus pneumoniae.1 The National Advisory Committee on Immunization has recently updated its guidelines about adults who qualify for immunization.

The burden of disease in Canada from pneumococcal disease is increasing dramatically. Approximately 1500 Canadian adults die each year from the infection.1 Typically, the disease presents as pneumonia, advancing to sepsis as the main cause of death.

Approach

There are 2 types of pneumococcal vaccines for adults in Canada—conjugate and polysaccharide. The conjugate vaccines—the 13-valent pneumococcal conjugate vaccine (Pneu-C-13) and the 10-valent adsorbed pneumococcal conjugate vaccine with nontypeable Haemophilus influenzae protein D, diphtheria, or tetanus toxoid—are delivered intramuscularly. The 23-valent pneumococcal polysaccharide vaccine (Pneu-P-23) is delivered intramuscularly or subcutaneously. Polysaccharide vaccines stimulate shorter-lasting immunoglobulin M antibodies and do not stimulate immunologic memory. Conjugate vaccines stimulate long-term immunity (immunoglobulin G antibodies).2 Efficacy for these vaccines has been demonstrated in large randomized controlled trials.3

Healthy adults

All healthy adults older than 65 years of age should receive 1 dose of Pneu-P-23 unless there are contraindications. Immunocompetent adults in long-term care facilities, those with a history of alcoholism, smokers, illicit drug users, and those who are homeless should also receive Pneu-P-23.4

High-risk adults

Patients at the highest risk (those with immunosuppression or who have chronic diseases) should receive the conjugate vaccine, followed by the polysaccharide vaccine 8 weeks later. High-risk patients include those with either congenital or acquired immunosuppression (eg, through organ transplantation, HIV infection, chemotherapy or radiation treatment, or immunosuppressant medications [eg, high-dose steroids, antirejection drugs, biologic medications]). Relevant chronic diseases include hyposplenism or asplenia, chronic renal disease or dialysis treatment, and neurologic disorders such as chronic cerebrospinal fluid leak or conditions that impair oral secretion clearance.5

Of note, a diagnosis of asthma, regardless of hospitalization, has recently been included as a high-risk factor. Individuals who required medical attention for asthma in the past 12 months should be vaccinated using the pneumococcal vaccine (conjugate or polysaccharide) and schedule recommended for their age group. Children and adolescents younger than 18 years of age should receive both Pneu-C-13 and Pneu-P-23. For adults, only Pneu-P-23 is generally recommended. No re-immunization is recommended.5

Contraindications and coadministration with other vaccines

Pneumococcal vaccines are contraindicated in patients with a history of anaphylaxis after vaccination, those with allergy to components of the vaccine (eg, diphtheria carrier protein, Pneu-C-13, latex), or those who are diphtheria or tetanus toxoid carriers. Vaccines can be given during a minor illness, regardless of fever, but should be avoided in severe illness. A Pneu-C-13 dose should be administered at least 1 year after any previous dose of Pneu-P-23. A Pneu-P-23 dose can be given 8 weeks after Pneu-C-13. Both vaccines can be coadministered with the varicella-zoster and influenza vaccines.6

Conclusion

Increasing the rate of pneumococcal vaccination will help decrease the burden of disease in both healthy and immunocompromised patients.

Footnotes

  • This article has been peer reviewed.

  • Competing interests

    Dr Brown is a board member of Immunize Canada and a speaker for Merck and Pfizer.

  • Copyright© the College of Family Physicians of Canada

References

  1. 1.↵
    1. Environics Research Group
    . Canadian Adult National Immunization Coverage (Adult NICS) survey—2006. Ottawa, ON: Public Health Agency of Canada; 2006.
  2. 2.↵
    1. Public Health Agency of Canada [website]
    . Canadian immunization guide. Preparations authorized for use in Canada. Ottawa, ON: Public Health Agency of Canada; 2014. Available from: www.phac-aspc.gc.ca/publicat/cig-gci/p04-pneueng.php#approve. Accessed 2014 Apr 26.
  3. 3.↵
    1. Grabenstein JD,
    2. Manoff SB
    . Pneumococcal polysaccharide 23-valent vaccine: long-term persistence of circulating antibody and immunogenicity and safety after revaccination in adults. Vaccine 2012;30(30):4435-44. Epub 2012 Apr 26.
    OpenUrlPubMed
  4. 4.↵
    1. Public Health Agency of Canada [website]
    . Canadian immunization guide. Recommendations for use. Ottawa, ON: Public Health Agency of Canada; 2014. Available from: www.phac-aspc.gc.ca/publicat/cig-gci/p04-pneu-eng.php#ru. Accessed 2014 Apr 26.
  5. 5.↵
    1. Public Health Agency of Canada [website]
    . Canadian immunization guide. Vaccine administration. Ottawa, ON: Public Health Agency of Canada; 2014. Available from: www.phacaspc.gc.ca/publicat/cig-gci/p04-pneu-eng.php#admin. Accessed 2014 Apr 26.
  6. 6.↵
    1. Public Health Agency of Canada [website]
    . Canadian immunization guide. Contraindications and precautions. Ottawa, ON: Public Health Agency of Canada; 2014. Available from: www.phac-aspc.gc.ca/publicat/cig-gci/p04-pneu-eng.php#contt. Accessed 2014 Apr 26.
PreviousNext
Back to top

In this issue

Canadian Family Physician: 61 (9)
Canadian Family Physician
Vol. 61, Issue 9
1 Sep 2015
  • Table of Contents
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on The College of Family Physicians of Canada.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Adult pneumococcal immunization
(Your Name) has sent you a message from The College of Family Physicians of Canada
(Your Name) thought you would like to see the The College of Family Physicians of Canada web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Adult pneumococcal immunization
Pamela Liao, Vivien Brown
Canadian Family Physician Sep 2015, 61 (9) 763;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Adult pneumococcal immunization
Pamela Liao, Vivien Brown
Canadian Family Physician Sep 2015, 61 (9) 763;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Approach
    • Conclusion
    • Footnotes
    • References
  • eLetters
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Managing type 2 diabetes in primary care during COVID-19
  • Effectiveness of dermoscopy in skin cancer diagnosis
  • Spontaneous pneumothorax in children
Show more Practice

Similar Articles

Navigate

  • Home
  • Current Issue
  • Archive
  • Collections - English
  • Collections - Française

For Authors

  • Authors and Reviewers
  • Submit a Manuscript
  • Permissions
  • Terms of Use

General Information

  • About CFP
  • About the CFPC
  • Advertisers
  • Careers & Locums
  • Editorial Advisory Board
  • Subscribers

Journal Services

  • Email Alerts
  • Twitter
  • LinkedIn
  • Instagram
  • RSS Feeds

Copyright © 2025 by The College of Family Physicians of Canada

Powered by HighWire